AI eye on cancer: robot reads slides Mid-Surgery to zap every last cell
NCT ID NCT06600165
First seen Sep 30, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This study tests whether artificial intelligence can help surgeons analyze microscope images during surgery for basal cell carcinoma, the most common skin cancer. The AI would instantly tell the difference between cancer, normal tissue, and inflamed tissue, helping doctors remove all the cancer in one go. The study will enroll 1000 patients and aims to make surgery faster and more precise.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinic and Policlinic of Dermatology and Allergy, LMU Munich
RECRUITINGMunich, Bavaria, 80337, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.